- Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022
- Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center
- Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio
As of last trade
Haemonetics Corp (HAZ:MUN) traded at 81.00, -4.71% below its 52-week high of 85.00, set on Nov 02, 2022.
40.40Jan 31 202285.00Nov 02 2022
Markit short selling activity
|Market cap||4.26bn USD|
|EPS (TTM)||1.67 |
Data delayed at least 15 minutes, as of Dec 07 2022 07:00 GMT.